Markus J. Cappel - 01 Jan 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role: Chief Bus. Officer & Treasurer
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jan 2022
Net transactions value: -$420,099
Form type: 4
Filing time: 04 Jan 2022, 20:35:20 UTC
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$0	+6,667	+7.8%	$0.000000	92,493	01 Jan 2022	Direct	F1
transaction	CCXI	Common Stock	Options Exercise	$0	+7,767	+8.4%	$0.000000	100,260	01 Jan 2022	Direct	F2
transaction	CCXI	Common Stock	Options Exercise	$0	+6,500	+6.5%	$0.000000	106,760	01 Jan 2022	Direct	F3
transaction	CCXI	Common Stock	Tax liability	$420,099	-11,538	-11%	$36.41	95,222	01 Jan 2022	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Restricted Stock Units	Options Exercise		-6,667	-100%		0	01 Jan 2022	Common Stock	6,667		Direct	F5, F6
transaction	CCXI	Restricted Stock Units	Options Exercise		-7,767	-50%		7,767	01 Jan 2022	Common Stock	7,767		Direct	F5, F7
transaction	CCXI	Restricted Stock Units	Options Exercise		-6,500	-33%		13,000	01 Jan 2022	Common Stock	6,500		Direct	F5, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019.
F2	Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020.
F3	Shares were acquired upon vesting of restricted stock units awarded on February 25, 2021.
F4	Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
F5	Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F6	The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F7	The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F8	The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.